Esta triple seal sobre tres dianas moleculares distintas sistema nervioso central, pncreas y tejido heptico define el perfil farmacolgico ms amplio documentado hasta la fecha en la familia de los agonistas de incretinas
Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial
It can matter for indication, coverage, cost, dose form, patient instructions, and savings-card eligibility
Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach
This agent differs from earlier therapies that were designed to reduce myocardial loading or induce neurohumoral blockade
Asimismo, los tiempos pueden variar segn el da de la semana y el volumen de operaciones